Skip to main content
Clinical Trials/JPRN-jRCT1062210054
JPRN-jRCT1062210054
Recruiting
未知

Effect of combined hyperbaric oxygen therapy on anterior cruciate ligament reconstruction

Enokida Makoto0 sites80 target enrollmentDecember 1, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
anterior cruciate ligament injury
Sponsor
Enokida Makoto
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Enokida Makoto

Eligibility Criteria

Inclusion Criteria

  • 1\) Men and women aged 14 to 45 at the time of consent, 2\) Patients with traumatic anterior cruciate ligament injury (whether fresh or old), 3\) Patients with consent from the substitute

Exclusion Criteria

  • 1\)Patients with inflammatory disease
  • 2\) Patients with intra\-articular fracture and osteochondral injury
  • 3\) Patients using bone metabolism regulators
  • 4\) Patients receiving hyperbaric oxygen therapy within 1 month prior to obtaining consent
  • 5\) Patients with compound ligament injury who require surgical treatment for ligament injuries other than the anterior cruciate ligament
  • 6\) Patients with a history of surgical treatment on the affected knee
  • 7\) Patients with physical or mental illness who cannot perform MRI examination
  • 8\) Chronic lung disease, chronic sinusitis, nasal polyps, upper respiratory tract inflammation and other sinus stenosis have been pointed out, pneumothorax history, other laryngological diseases, etc.
  • 9\) When it is judged that HBO continuation is not preferable due to the exacerbation of the underlying disease
  • 10\) Patients found to be pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials